CONVERGE Post-Approval Study (PAS)
NCT: NCT05393180 · ACTIVE_NOT_RECRUITING
Реклама
NCT IDNCT05393180
СтатусACTIVE_NOT_RECRUITING
Дата начала2022-04-13
Завершение2028-11-21
Краткое описание
The primary objective of CONVERGE PAS is to evaluate clinical outcomes (peri-procedural and long-term) in a cohort of patients treated during commercial use of the EPi-Sense® Guided Coagulation System or EPi-Sense ST™ Coagulation System to treat symptomatic long-standing persistent atrial fibrillation (AF) patients who are refractory or intolerant to at least one Class I and/or III AAD.
Официальный источник
Открыть на ClinicalTrials.gov →Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.